Year |
Citation |
Score |
2023 |
Du XL, Li Z. Incidence trends in triple-negative breast cancer among women in the United States from 2010 to 2019 by race/ethnicity, age and tumor stage. American Journal of Cancer Research. 13: 678-691. PMID 36895969 |
0.308 |
|
2022 |
Fwelo P, Yusuf ZI, Adjei A, Huynh G, Du XL. Racial and ethnic disparities in the refusal of surgical treatment in women 40 years and older with breast cancer in the USA between 2010 and 2017. Breast Cancer Research and Treatment. 194: 643-661. PMID 35749020 DOI: 10.1007/s10549-022-06653-w |
0.318 |
|
2022 |
Du X. Racial disparities in health insurance, triple-negative breast cancer diagnosis, tumor stage, treatment and survival in a large nationwide SEER cohort in the United States. Molecular and Clinical Oncology. 16: 95. PMID 35368847 DOI: 10.3892/mco.2022.2528 |
0.342 |
|
2022 |
Du XL, Song L. Age and Racial Disparities in the Utilization of Anticancer, Antihypertension, and Anti-diabetes Therapies, and in Mortality in a Large Population-Based Cohort of Older Women with Breast Cancer. Journal of Racial and Ethnic Health Disparities. PMID 35040106 DOI: 10.1007/s40615-022-01235-4 |
0.309 |
|
2021 |
Du XL, Song L. Breast cancer incidence trends in Asian women aged 20 or older as compared to other ethnic women in the United States from 2000 to 2018 by time period, age and tumor stage. Cancer Epidemiology. 76: 102076. PMID 34861613 DOI: 10.1016/j.canep.2021.102076 |
0.326 |
|
2019 |
Farias AJ, Ochoa CY, Toledo G, Bang SI, Hamilton AS, Du XL. Racial/ethnic differences in patient experiences with health care in association with earlier stage at breast cancer diagnosis: findings from the SEER-CAHPS data. Cancer Causes & Control : Ccc. PMID 31797123 DOI: 10.1007/S10552-019-01254-3 |
0.439 |
|
2019 |
Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Zhao B, Du XL. Comparative Effectiveness of Chemotherapy, Rituximab, and Bendamustine in Medicare Beneficiaries With Mantle-Cell Lymphoma. Clinical Lymphoma, Myeloma & Leukemia. PMID 31563564 DOI: 10.1016/J.Clml.2019.08.014 |
0.342 |
|
2019 |
Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis. Head & Neck. PMID 31441572 DOI: 10.1002/Hed.25923 |
0.319 |
|
2019 |
Mungi C, Lai D, Du XL. Spatial Analysis of Industrial Benzene Emissions and Cancer Incidence Rates in Texas. International Journal of Environmental Research and Public Health. 16. PMID 31344779 DOI: 10.3390/Ijerph16152627 |
0.314 |
|
2019 |
Zhu P, Du XL, Zhu JJ, Esquenazi Y. Improved survival of glioblastoma patients treated at academic and high-volume facilities: a hospital-based study from the National Cancer Database. Journal of Neurosurgery. 1-12. PMID 30771780 DOI: 10.3171/2018.10.Jns182247 |
0.416 |
|
2019 |
Davis CH, Gaglani T, Moore LW, Du XL, Hwang H, Yamal JM, Bailey HR, Cusick MV. Trends and Outcomes in Laparoscopic versus Open Surgery for Rectal Cancer from 2005 to 2016 Using the ACS-NSQIP Database, a Retrospective Cohort Study. International Journal of Surgery (London, England). PMID 30771485 DOI: 10.1016/J.Ijsu.2019.02.006 |
0.371 |
|
2019 |
Nguyen C, Lairson DR, Swartz MD, Du XL. Cost-Effectiveness of Adding Androgen Deprivation Therapy to Radiation Therapy for Men with Advanced Prostate Cancer from a U.S. Payer's Perspective. Journal of Managed Care & Specialty Pharmacy. 25: 225-234. PMID 30698095 DOI: 10.18553/Jmcp.2019.25.2.225 |
0.312 |
|
2019 |
Zhu P, Du XL, Esquenazi Y, Zhu J. Access to clinical trials, multidisciplinary environment, and health care providers by facility type and outcomes of patients with newly diagnosed glioblastoma using SEER-Medicare dataset. Journal of Clinical Oncology. 37: e13576-e13576. DOI: 10.1200/Jco.2019.37.15_Suppl.E13576 |
0.386 |
|
2019 |
Kabadi SM, Goyal RK, Nagar SP, Davis KL, Le H, Du XL, Jain P, Wang ML, Romaguera JE, Kaye JA. Overall Survival, Adverse Events, and Economic Burden in Medicare-Insured Patients with Mantle Cell Lymphoma Receiving Cancer-Directed Therapy Blood. 134: 63-63. DOI: 10.1182/Blood-2019-122841 |
0.464 |
|
2019 |
Zhu P, Du X, Zhu J. EPID-16. COMPARATIVE ANALYSIS OF OVERALL SURVIVAL AND ADVERSE EVENTS BY ADJUVANT TREATMENT MODALITIES IN ELDERLY PATIENTS WITH GLIOBLASTOMA USING THE SEER-MEDICARE DATABASE Neuro-Oncology. 21: vi77-vi78. DOI: 10.1093/Neuonc/Noz175.316 |
0.395 |
|
2018 |
Fu S, Wang M, Li R, Lairson DR, Zhao B, Du XL. Increase in survival for patients with mantle cell lymphoma in the era of novel agents in 1995-2013: Findings from Texas and national SEER areas. Cancer Epidemiology. 58: 89-97. PMID 30528835 DOI: 10.1016/J.Canep.2018.12.002 |
0.384 |
|
2018 |
Farias AJ, Wu WH, Du XL. Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data. Bmc Cancer. 18: 1214. PMID 30514270 DOI: 10.1186/S12885-018-5121-Z |
0.431 |
|
2018 |
Chen TH, Du XL, Chan W, Zhang K. Impacts of cold weather on emergency hospital admission in Texas, 2004-2013. Environmental Research. 169: 139-146. PMID 30453131 DOI: 10.1016/J.Envres.2018.10.031 |
0.334 |
|
2018 |
Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Gunn GB, Lai SY, Fuller CD, Hanna EY, Rosenthal DI, Lewin JS, Piller LB, Hutcheson KA. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. Jama Otolaryngology-- Head & Neck Surgery. PMID 30193299 DOI: 10.1001/Jamaoto.2018.1791 |
0.338 |
|
2018 |
Nguyen C, Lairson DR, Swartz MD, Du XL. Risks of Major Long-term Side Effects Associated with Androgen Deprivation Therapy in Men with Prostate Cancer. Pharmacotherapy. PMID 30080934 DOI: 10.1002/Phar.2168 |
0.336 |
|
2018 |
Nguyen C, Lairson DR, Swartz MD, Du XL. Racial, Socioeconomic, and Geographic Disparities in the Receipt, Timing to Initiation, and Duration of Adjuvant Androgen Deprivation Therapy in Men with Prostate Cancer. Journal of Racial and Ethnic Health Disparities. PMID 29959759 DOI: 10.1007/S40615-018-0508-8 |
0.344 |
|
2018 |
Farias AJ, Wu WH, Du XL. Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer. Medical Oncology (Northwood, London, England). 35: 113. PMID 29926275 DOI: 10.1007/S12032-018-1168-6 |
0.502 |
|
2018 |
Kim J, Rajan SS, Du XL, Franzini L, Giordano SH, Morgan RO. Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas. Breast Cancer Research and Treatment. PMID 29423900 DOI: 10.1007/S10549-018-4704-3 |
0.379 |
|
2018 |
Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BD. Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer. PMID 29393964 DOI: 10.1002/Cncr.31155 |
0.427 |
|
2018 |
Chen Y, Lairson DR, Chan W, Du XL. Risk of adverse events associated with front-line anti-myeloma treatment in Medicare patients with multiple myeloma. Annals of Hematology. PMID 29333596 DOI: 10.1007/S00277-018-3238-4 |
0.382 |
|
2018 |
Tam S, Du XL, Lewis CM, Yamal J, Weber RS. The effect of facility volume on treatment guideline compliance and overall survival in oral tongue squamous cell carcinoma. Journal of Clinical Oncology. 36: 17-17. DOI: 10.1200/Jco.2018.36.30_Suppl.17 |
0.428 |
|
2018 |
Fu S, Wang M, Zhao H, Li R, Lairson DR, Giordano SH, Du XL. Effects of bendamustine, bortezomib, and rituximab on 1-year survival rates in elderly patients newly diagnosed with mantle cell lymphoma. Journal of Clinical Oncology. 36: e19537-e19537. DOI: 10.1200/Jco.2018.36.15_Suppl.E19537 |
0.363 |
|
2018 |
Zhu P, Du X, Esquenazi Y, Zhu J. EPID-01. ASSOCIATIONS OF TIMING OF ADJUVANT THERAPIES, RADIATION FRACTIONS AND RADIATION DOSES WITH GLIOBLASTOMA SURVIVAL: A RETROSPECTIVE COHORT ANALYSIS USING THE NATIONAL CANCER DATABASE AND SEER-MEDICARE DATABASE Neuro-Oncology. 20: vi80-vi80. DOI: 10.1093/Neuonc/Noy148.328 |
0.359 |
|
2018 |
Zhu P, Du XL, Esquenazi Y, Zhu J. 51 Timing of adjuvant treatments on glioblastoma survival: A retrospective cohort analysis based on the national cancer database Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques. 45: S11-S12. DOI: 10.1017/Cjn.2018.291 |
0.415 |
|
2018 |
Fu S, Wang M, Zhao H, Li R, Lairson D, Giordano S, Zhao B, Du X. Effects of Rituximab, Bortezomib, and Bendamustine on the Survival in Medicare Beneficiaries with Mantle Cell Lymphoma Clinical Lymphoma Myeloma and Leukemia. 18: S273-S274. DOI: 10.1016/J.Clml.2018.07.198 |
0.336 |
|
2017 |
Fu S, Wang M, Lairson DR, Li R, Zhao B, Du XL. Trends and variations in mantle cell lymphoma incidence from 1995 to 2013: A comparative study between Texas and National SEER areas. Oncotarget. 8: 112516-112529. PMID 29348844 DOI: 10.18632/Oncotarget.22367 |
0.358 |
|
2017 |
Wu Y, Liu H, Du XL, Wang F, Zhang J, Cui X, Li E, Yang J, Yi M, Zhang Y. Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II-IV rectal cancer. Oncotarget. 8: 106913-106925. PMID 29290999 DOI: 10.18632/Oncotarget.22460 |
0.449 |
|
2017 |
Yang J, Du XL, Li S, Wu Y, Lv M, Dong D, Zhang L, Chen Z, Wang B, Wang F, Shen Y, Li E, Yi M, Yang J. The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012. Bmc Cancer. 17: 783. PMID 29166866 DOI: 10.1186/S12885-017-3765-8 |
0.398 |
|
2017 |
Zhao H, Zhang N, Ho V, Ding M, He W, Niu J, Yang M, Du XL, Zorzi D, Chavez-MacGregor M, Giordano SH. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011. Cancer. PMID 29140558 DOI: 10.1002/Cncr.31094 |
0.434 |
|
2017 |
Chen Y, Lairson DR, Chan W, Du XL. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort. Medical Oncology (Northwood, London, England). 34: 153. PMID 28776319 DOI: 10.1007/S12032-017-1001-7 |
0.432 |
|
2017 |
Farias AJ, Du XL. Racial differences in adjuvant endocrine therapy use and discontinuation in association with mortality among Medicare breast cancer patients by receptor status. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28515111 DOI: 10.1158/1055-9965.Epi-17-0280 |
0.412 |
|
2017 |
Zhu P, Du XL, Lu G, Zhu JJ. Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study. Oncotarget. PMID 28467795 DOI: 10.18632/Oncotarget.17054 |
0.423 |
|
2017 |
Chen Z, Ren Y, Du XL, Yang J, Shen Y, Li S, Wu Y, Lv M, Dong D, Li E, Li W, Liu P, Yang J, Yi M. Incidence and survival differences in esophageal cancer among ethnic groups in the United States. Oncotarget. PMID 28410201 DOI: 10.18632/Oncotarget.16694 |
0.405 |
|
2017 |
Farias AJ, Du XL. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 35: 86-95. PMID 28034069 DOI: 10.1200/Jco.2016.68.2807 |
0.428 |
|
2017 |
Parikh RC, Du XL, Robert MO, Lairson DR. Cost-Effectiveness of Treatment Sequences of Chemotherapies and Targeted Biologics for Elderly Metastatic Colorectal Cancer Patients. Journal of Managed Care & Specialty Pharmacy. 23: 64-73. PMID 28025930 DOI: 10.18553/Jmcp.2017.23.1.64 |
0.4 |
|
2017 |
Zhu P, Du X, Zhu J, Esquenazi Y. HOUT-12. IMPROVED SURVIVAL OF GLIOBLASTOMA PATIENTS TREATED AT ACADEMIC CANCER PROGRAMS: A HOSPITAL-BASED STUDY FROM THE NATIONAL CANCER DATABASE Neuro-Oncology. 19: vi108-vi108. DOI: 10.1093/Neuonc/Nox168.443 |
0.436 |
|
2017 |
Zhu P, Du X, Lu G, Zhu J. EPID-02. SURVIVAL BENEFIT OF GLIOBLASTOMA PATIENTS AFTER FDA APPROVAL OF BEVACIZUMAB, A POPULATION-BASED STUDY USING SEER, TCR, AND NCDB DATABASES Neuro-Oncology. 19: vi69-vi69. DOI: 10.1093/Neuonc/Nox168.280 |
0.376 |
|
2016 |
Yang J, Du XL, Li ST, Wang BY, Wu YY, Chen ZL, Lv M, Shen YW, Wang X, Dong DF, Li D, Wang F, Li EX, Yi M, Yang J. Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients. Plos One. 11: e0167540. PMID 27936129 DOI: 10.1371/Journal.Pone.0167540 |
0.409 |
|
2016 |
Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients. Drugs - Real World Outcomes. 3: 69-82. PMID 27747803 DOI: 10.1007/S40801-015-0059-9 |
0.438 |
|
2016 |
Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Use of Hematopoietic Growth Factors and Risk of Thromboembolic and Pulmonary Toxicities in Elderly Patients with Advanced Ovarian Cancer. Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health. PMID 27365286 DOI: 10.1016/J.Whi.2016.05.007 |
0.404 |
|
2016 |
Li D, Du XL, Ren Y, Liu P, Li S, Yang J, Lv M, Chen L, Wang X, Li E, Yang J, Yi M. Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer. Plos One. 11: e0156617. PMID 27244238 DOI: 10.1371/Journal.Pone.0156617 |
0.448 |
|
2016 |
Liu Z, Zhang K, Du XL. Risks of developing breast and colorectal cancer in association with incomes and geographic locations in Texas: a retrospective cohort study. Bmc Cancer. 16: 294. PMID 27118258 DOI: 10.1186/S12885-016-2324-Z |
0.438 |
|
2016 |
Parikh RC, Du XL, Morgan RO, Lairson DR. Patterns of Treatment Sequences in Chemotherapy and Targeted Biologics for Metastatic Colorectal Cancer: Findings from a Large Community-Based Cohort of Elderly Patients. Drugs - Real World Outcomes. 3: 69-82. PMID 27073759 DOI: 10.1007/s40801-015-0059-9 |
0.329 |
|
2016 |
Du XL, Zhang Y, Hardy D. Associations between hematopoietic growth factors and risks of venous thromboembolism, stroke, ischemic heart disease and myelodysplastic syndrome: findings from a large population-based cohort of women with breast cancer. Cancer Causes & Control : Ccc. PMID 27059219 DOI: 10.1007/S10552-016-0742-5 |
0.368 |
|
2016 |
Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare Part D. Medical Oncology (Northwood, London, England). 33: 19. PMID 26786154 DOI: 10.1007/S12032-016-0732-1 |
0.46 |
|
2016 |
Farias A, Du XL. Racial/ethnic difference in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer. Journal of Clinical Oncology. 34: e18076-e18076. DOI: 10.1200/Jco.2016.34.15_Suppl.E18076 |
0.433 |
|
2016 |
Parikh R, Du X, Morgan R, Lairson D. Cost Effectiveness of Treatment Sequences for Elderly Metastatic Colorectal Cancer Patients: A Seer-Medicare-Based Modelling Analysis Value in Health. 19: A150. DOI: 10.1016/J.Jval.2016.03.1590 |
0.397 |
|
2015 |
Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: 1070-8. PMID 26686793 DOI: 10.1016/J.Jval.2015.08.008 |
0.399 |
|
2015 |
Zhang Y, Franzini L, Chan W, Xu H, Du XL. Effects of Health Insurance on Tumor Stage, Treatment, and Survival in Large Cohorts of Patients with Breast and Colorectal Cancer. Journal of Health Care For the Poor and Underserved. 26: 1336-58. PMID 26548682 DOI: 10.1353/Hpu.2015.0119 |
0.497 |
|
2015 |
Poonawalla IB, Piller LB, Lairson DR, Chan W, Du XL. Impact of Hematopoietic Growth Factors on Blood Transfusion Needs, Incidence of Neutropenia, and Overall Survival Among Elderly Advanced Ovarian Cancer Patients Treated With Chemotherapy. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 26509851 DOI: 10.1097/Igc.0000000000000564 |
0.445 |
|
2015 |
Du XL, Parikh RC, Lairson DR. Racial and geographic disparities in the patterns of care and costs at the end of life for patients with lung cancer in 2007-2010 after the 2006 introduction of bevacizumab. Lung Cancer (Amsterdam, Netherlands). PMID 26439736 DOI: 10.1016/J.Lungcan.2015.09.017 |
0.379 |
|
2015 |
Du XL, Zhang Y, Parikh RC, Lairson DR, Cai Y. Comparative Effectiveness of Chemotherapy Regimens in Prolonging Survival for Two Large Population-Based Cohorts of Elderly Adults with Breast and Colon Cancer in 1992-2009. Journal of the American Geriatrics Society. PMID 26200214 DOI: 10.1111/Jgs.13523 |
0.465 |
|
2015 |
Du XL, Zhang Y. Risks of Venous Thromboembolism, Stroke, Heart Disease, and Myelodysplastic Syndrome Associated With Hematopoietic Growth Factors in a Large Population-Based Cohort of Patients With Colorectal Cancer. Clinical Colorectal Cancer. PMID 26119923 DOI: 10.1016/J.Clcc.2015.05.007 |
0.372 |
|
2015 |
Poonawalla IB, Lairson DR, Chan W, Piller LB, Du XL. Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 18: 387-95. PMID 26091592 DOI: 10.1016/J.Jval.2015.01.005 |
0.416 |
|
2015 |
Poonawalla IB, Parikh RC, Du XL, VonVille HM, Lairson DR. Cost Effectiveness of Chemotherapeutic Agents and Targeted Biologics in Ovarian Cancer: A Systematic Review. Pharmacoeconomics. PMID 26072142 DOI: 10.1007/S40273-015-0304-9 |
0.431 |
|
2015 |
Ludwig MS, Kuban DA, Strom SS, Du XL, Lopez DS, Yamal JM. Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy. American Journal of Men's Health. PMID 25891393 DOI: 10.1177/1557988315581396 |
0.365 |
|
2015 |
Ludwig MS, Kuban DA, Du XL, Lopez DS, Yamal JM, Strom SS. The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation. Bmc Cancer. 15: 190. PMID 25885406 DOI: 10.1186/S12885-015-1180-6 |
0.325 |
|
2015 |
Wang X, Du XL. Socio-demographic and geographic variations in the utilization of hormone therapy in older women with breast cancer after Medicare Part-D coverage. Medical Oncology (Northwood, London, England). 32: 154. PMID 25837434 DOI: 10.1007/S12032-015-0599-6 |
0.413 |
|
2015 |
Liu Z, Zhang Y, Franzin L, Cormier JN, Chan W, Xu H, Du XL. Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data. International Journal of Oncology. 46: 1819-26. PMID 25672365 DOI: 10.3892/Ijo.2015.2881 |
0.447 |
|
2015 |
Huo J, Du XL, Lairson DR, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Utilization of surgery, chemotherapy, radiation therapy, and hospice at the end of life for patients diagnosed with metastatic melanoma. American Journal of Clinical Oncology. 38: 235-41. PMID 23648436 DOI: 10.1097/Coc.0B013E31829378F9 |
0.338 |
|
2015 |
Kadakia A, Rajan SS, Abughosh S, Du XL, Johnson ML. CMF-regimen preferred as first-course chemotherapy for older and sicker women with breast cancer: Findings from a SEER-Medicare-based population study. American Journal of Clinical Oncology. 38: 165-73. PMID 23608830 DOI: 10.1097/Coc.0B013E31828F5B01 |
0.467 |
|
2015 |
Parikh R, Du X, Morgan R, Lairson D. Treatment patterns among elderly Metastatic Colorectal Cancer patients - a seer-medicare analysis Value in Health. 18: A221. DOI: 10.1016/J.Jval.2015.03.1282 |
0.419 |
|
2014 |
Du XL, Zhang Y, Hardy D. Temporal and Geographic Variations in the Receipt of Colony-Stimulating Factors and Erythropoiesis-Stimulating Agents in a Large Retrospective Cohort of Older Women With Breast Cancer From 2000 to 2009. American Journal of Therapeutics. PMID 25756469 DOI: 10.1097/Mjt.0000000000000182 |
0.472 |
|
2014 |
Tong L, Ahn C, Symanski E, Lai D, Du XL. Relative impact of earlier diagnosis and improved treatment on survival for colorectal cancer: a US database study among elderly. Cancer Epidemiology. 38: 733-40. PMID 25454261 DOI: 10.1016/J.Canep.2014.10.004 |
0.463 |
|
2014 |
Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi M. Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. Plos One. 9: e110281. PMID 25333877 DOI: 10.1371/Journal.Pone.0110281 |
0.389 |
|
2014 |
Russell HV, Okcu MF, Kamdar K, Shah MD, Kim E, Swint JM, Chan W, Du XL, Franzini L, Ho V. Algorithm for analysis of administrative pediatric cancer hospitalization data according to indication for admission. Bmc Medical Informatics and Decision Making. 14: 88. PMID 25274165 DOI: 10.1186/1472-6947-14-88 |
0.374 |
|
2014 |
Zhang Y, Fu SS, Du XL. Increasing utilization and predictors of hematopoietic growth factors in patients diagnosed with colorectal cancer: findings from a large national population-based cohort in the USA, 1992-2009. Medical Oncology (Northwood, London, England). 31: 242. PMID 25231751 DOI: 10.1007/S12032-014-0242-Y |
0.48 |
|
2014 |
Clague J, Reynolds P, Henderson KD, Sullivan-Halley J, Ma H, Lacey JV, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L. Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study. Plos One. 9: e103735. PMID 25079077 DOI: 10.1371/Journal.Pone.0103735 |
0.416 |
|
2014 |
Rajan SS, Cai Y, Yi M, Tsai CL, Du XL. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study. American Journal of Clinical Oncology. PMID 25068470 DOI: 10.1097/Coc.0000000000000104 |
0.446 |
|
2014 |
Lairson DR, Parikh RC, Cormier JN, Chan W, Du XL. Cost-utility analysis of chemotherapy regimens in elderly patients with stage III colon cancer. Pharmacoeconomics. 32: 1005-13. PMID 24920195 DOI: 10.1007/S40273-014-0180-8 |
0.47 |
|
2014 |
Huo J, Lairson DR, Du XL, Chan W, Jiang J, Buchholz TA, Guadagnolo BA. Hospital Case Volume is Associated With Improved Survival for Patients With Metastatic Melanoma. American Journal of Clinical Oncology. PMID 24755661 DOI: 10.1097/Coc.0000000000000074 |
0.377 |
|
2014 |
Tong L, Ahn C, Symanski E, Lai D, Du XL. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer Annals of Oncology. 25: 1234-1242. PMID 24681607 DOI: 10.1093/Annonc/Mdu131 |
0.471 |
|
2014 |
Tong L, Ahn C, Symanski E, Lai D, Du XL. Temporal trends in the leading causes of death among a large national cohort of patients with colorectal cancer from 1975 to 2009 in the United States. Annals of Epidemiology. 24: 411-7. PMID 24529646 DOI: 10.1016/J.Annepidem.2014.01.005 |
0.37 |
|
2014 |
Lairson DR, Parikh RC, Cormier JN, Du XL. Cost-utility analysis of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 17: 34-42. PMID 24438715 DOI: 10.1016/J.Jval.2013.11.007 |
0.435 |
|
2014 |
Panchal JM, Lairson DR, Chan W, Du XL. Geographic Variation in Oxaliplatin Chemotherapy and Survival in Patients With Colon Cancer. American Journal of Therapeutics. PMID 24368611 DOI: 10.1097/Mjt.0000000000000015 |
0.475 |
|
2014 |
Poonawalla I, Lairson D, Du X. Cost Assessment of Advanced Ovarian Cancer Treatment in a Large Cohort of Elderly Patients Value in Health. 17: A80. DOI: 10.1016/J.Jval.2014.03.467 |
0.429 |
|
2013 |
Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Du XL. Utilization of lymph node dissection, race/ethnicity, and breast cancer outcomes. The American Journal of Managed Care. 19: 805-10. PMID 24304159 |
0.703 |
|
2013 |
Nurgalieva ZZ, Franzini L, Morgan R, Vernon SW, Liu CC, Du XL. Surveillance mammography use after treatment of primary breast cancer and racial disparities in survival. Medical Oncology (Northwood, London, England). 30: 691. PMID 23975632 DOI: 10.1007/S12032-013-0691-8 |
0.765 |
|
2013 |
Liu P, Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi M. Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. British Journal of Cancer. 109: 1302-9. PMID 23907433 DOI: 10.1038/Bjc.2013.387 |
0.438 |
|
2013 |
Du XL, Cai Y, Symanski E. Association between chemotherapy and cognitive impairments in a large cohort of patients with colorectal cancer. International Journal of Oncology. 42: 2123-33. PMID 23563930 DOI: 10.3892/Ijo.2013.1882 |
0.469 |
|
2013 |
Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. British Journal of Cancer. 108: 1508-14. PMID 23470470 DOI: 10.1038/Bjc.2013.97 |
0.637 |
|
2013 |
Du XL, Parikh RC, Lairson DR, Giordano SH, Cen P. Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer. Medical Oncology (Northwood, London, England). 30: 440. PMID 23307252 DOI: 10.1007/S12032-012-0440-4 |
0.52 |
|
2013 |
Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Medical Oncology (Northwood, London, England). 30: 419. PMID 23292872 DOI: 10.1007/S12032-012-0419-1 |
0.76 |
|
2013 |
Panchal JM, Lairson DR, Chan W, Du XL. Geographic variation and sociodemographic disparity in the use of oxaliplatin-containing chemotherapy in patients with stage III colon cancer. Clinical Colorectal Cancer. 12: 113-21. PMID 23137529 DOI: 10.1016/J.Clcc.2012.09.007 |
0.495 |
|
2013 |
Liu L, Wang H, Chen Y, Rustveld L, Liu G, Du XL. Splenic marginal zone lymphoma: a population-based study on the 2001-2008 incidence and survival in the United States. Leukemia & Lymphoma. 54: 1380-6. PMID 23101590 DOI: 10.3109/10428194.2012.743655 |
0.402 |
|
2012 |
Hosain GM, Sanderson M, Du XL, Chan W, Strom SS. Racial/ethnic differences in treatment discussed, preferred, and received for prostate cancer in a tri-ethnic population. American Journal of Men's Health. 6: 249-57. PMID 22419652 DOI: 10.1177/1557988311432467 |
0.394 |
|
2012 |
Sail KR, Franzini L, Lairson DR, Du XL. Clinical and economic outcomes associated with adjuvant chemotherapy in elderly patients with early stage operable breast cancer. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 15: 72-80. PMID 22264974 DOI: 10.1016/J.Jval.2011.10.004 |
0.49 |
|
2012 |
Abotchie PN, Vernon SW, Du XL. Gender differences in colorectal cancer incidence in the United States, 1975-2006. Journal of Women's Health (2002). 21: 393-400. PMID 22149014 DOI: 10.1089/Jwh.2011.2992 |
0.384 |
|
2012 |
Wang H, Chen Y, Li F, Delasalle K, Wang J, Alexanian R, Kwak L, Rustveld L, Du XL, Wang M. Temporal and geographic variations of Waldenstrom macroglobulinemia incidence: a large population-based study. Cancer. 118: 3793-800. PMID 22139816 DOI: 10.1002/Cncr.26627 |
0.305 |
|
2012 |
Cen P, Banki F, Cheng L, Khalil K, Du XL, Fallon M, Amato RJ, Kaiser LR. Changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States. Annals of Surgical Oncology. 19: 1685-91. PMID 22130619 DOI: 10.1245/S10434-011-2141-1 |
0.411 |
|
2012 |
Sail K, Franzini L, Lairson D, Du X. Differences in treatment and survival among African-American and Caucasian women with early stage operable breast cancer. Ethnicity & Health. 17: 309-23. PMID 22066691 DOI: 10.1080/13557858.2011.628011 |
0.45 |
|
2012 |
Cen P, Liu C, Du XL. Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer Annals of Oncology. 23: 1503-1511. PMID 22021820 DOI: 10.1093/Annonc/Mdr449 |
0.452 |
|
2012 |
Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in length of stay in hospice care by tumor stage in a large elderly cohort with non-small cell lung cancer. Palliative Medicine. 26: 61-71. PMID 21606129 DOI: 10.1177/0269216311407693 |
0.426 |
|
2012 |
Hu CY, Chan W, Delclos GP, Du XL. Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer. American Journal of Clinical Oncology. 35: 228-36. PMID 21383605 DOI: 10.1097/Coc.0B013E318210F812 |
0.659 |
|
2012 |
Panchal J, Lairson D, Chan W, Du X. PCN138 Geographic Variation and Socio-Demographic Disparity in the Utilization of Oxaliplatin-Containing Chemotherapy in Patients with Stage-III Colon Cancer Value in Health. 15: A233. DOI: 10.1016/J.Jval.2012.03.1255 |
0.454 |
|
2012 |
Kadakia A, Rajan S, Du X, Johnson M. PCN125 Predictors of Methotrexate Containing Chemotherapy in Women Diagnosed With Early Stage Breast Cancer Value in Health. 15: A230. DOI: 10.1016/J.Jval.2012.03.1242 |
0.422 |
|
2012 |
Lin LH, Du XL. Sequential chemotherapy and radiotherapy for the treatment of high risk postoperative endometrial cancer Chinese Journal of Cancer Prevention and Treatment. 19: 1109-1111. |
0.359 |
|
2011 |
Hu CY, Delclos GL, Chan W, Du XL. Post-treatment surveillance in a large cohort of patients with colon cancer. The American Journal of Managed Care. 17: 329-36. PMID 21718080 |
0.587 |
|
2011 |
White A, Vernon SW, Franzini L, Du XL. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 811-7. PMID 21546366 DOI: 10.1158/1055-9965.Epi-09-0963 |
0.562 |
|
2011 |
Hosain GM, Sanderson M, Du XL, Chan W, Strom SS. Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population. Central European Journal of Public Health. 19: 30-4. PMID 21526653 DOI: 10.21101/Cejph.A3622 |
0.341 |
|
2011 |
Hardy D, Chan W, Liu CC, Cormier JN, Xia R, Bruera E, Du XL. Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer. 117: 1506-15. PMID 21425152 DOI: 10.1002/Cncr.25669 |
0.351 |
|
2011 |
Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 253-62. PMID 21402294 DOI: 10.1016/J.Jval.2010.09.010 |
0.719 |
|
2011 |
White A, Coker AL, Du XL, Eggleston KS, Williams M. Racial/ethnic disparities in survival among men diagnosed with prostate cancer in Texas. Cancer. 117: 1080-8. PMID 21351084 DOI: 10.1002/Cncr.25671 |
0.614 |
|
2011 |
Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV, Henderson KD, Ursin G, West D, Chang S, Delclos GL, Du XL, Forman MR, Bernstein L. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 560-4. PMID 21266521 DOI: 10.1158/1055-9965.Epi-10-1182 |
0.357 |
|
2011 |
Du XL, Lin CC, Johnson NJ, Altekruse S. Effects of individual-level socioeconomic factors on racial disparities in cancer treatment and survival: findings from the National Longitudinal Mortality Study, 1979-2003. Cancer. 117: 3242-51. PMID 21264829 DOI: 10.1002/Cncr.25854 |
0.389 |
|
2011 |
Cheng L, Eng C, Nieman LZ, Kapadia AS, Du XL. Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005. American Journal of Clinical Oncology. 34: 573-80. PMID 21217399 DOI: 10.1097/Coc.0B013E3181Fe41Ed |
0.402 |
|
2011 |
Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Martinez CA, Heslop HE, Brenner MK, Krance RA. Children with acute leukemia: a comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatric Blood & Cancer. 56: 143-51. PMID 21108446 DOI: 10.1016/J.Bbmt.2009.12.403 |
0.31 |
|
2011 |
Du XL, Xia R, Burau K, Liu CC. Cardiac risk associated with the receipt of anthracycline and trastuzumab in a large nationwide cohort of older women with breast cancer, 1998-2005. Medical Oncology (Northwood, London, England). 28: S80-90. PMID 20967512 DOI: 10.1007/S12032-010-9717-7 |
0.45 |
|
2011 |
Hu CY, Delclos GL, Chan W, Du XL. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Medical Oncology (Northwood, London, England). 28: 1062-74. PMID 20714945 DOI: 10.1007/S12032-010-9644-7 |
0.663 |
|
2011 |
Nurgalieva Z, Liu CC, Du XL. Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer. Medical Oncology (Northwood, London, England). 28: 716-25. PMID 20361359 DOI: 10.1007/S12032-010-9512-5 |
0.753 |
|
2011 |
Liu CC, Xia R, Guadagnolo A, Cormier JN, Du XL. Risk of xerostomia in association with the receipt of radiation therapy in older patients with head and neck cancer. American Journal of Therapeutics. 18: 206-15. PMID 20068441 DOI: 10.1097/Mjt.0B013E3181C960Dc |
0.488 |
|
2010 |
Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy. Journal of the American Geriatrics Society. 58: 1885-95. PMID 20840455 DOI: 10.1111/J.1532-5415.2010.03081.X |
0.741 |
|
2010 |
Du XL, Liu CC. Racial/Ethnic disparities in socioeconomic status, diagnosis, treatment and survival among medicare-insured men and women with head and neck cancer. Journal of Health Care For the Poor and Underserved. 21: 913-30. PMID 20693735 DOI: 10.1353/Hpu.0.0331 |
0.455 |
|
2010 |
Gruschkus SK, Lairson D, Dunn JK, Risser J, Du XL. Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer. 116: 5279-89. PMID 20665502 DOI: 10.1002/Cncr.25525 |
0.752 |
|
2010 |
White A, Vernon SW, Franzini L, Du XL. Racial disparities in colorectal cancer survival: to what extent are racial disparities explained by differences in treatment, tumor characteristics, or hospital characteristics? Cancer. 116: 4622-31. PMID 20626015 DOI: 10.1002/Cncr.25395 |
0.66 |
|
2010 |
Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology (Baltimore, Md.). 52: 132-41. PMID 20578139 DOI: 10.1002/Hep.23615 |
0.3 |
|
2010 |
Guadagnolo BA, Liu CC, Cormier JN, Du XL. Evaluation of trends in the use of intensity-modulated radiotherapy for head and neck cancer from 2000 through 2005: socioeconomic disparity and geographic variation in a large population-based cohort. Cancer. 116: 3505-12. PMID 20564123 DOI: 10.1002/Cncr.25205 |
0.45 |
|
2010 |
Lin YF, Lairson DR, Chan W, Du XL, Leung KS, Kennedy-Nasser AA, Martinez CA, Gottschalk SM, Bollard CM, Heslop HE, Brenner MK, Krance RA. The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 16: 1272-81. PMID 20348004 DOI: 10.1016/J.Bbmt.2010.03.016 |
0.347 |
|
2010 |
Hardy D, Liu CC, Cormier JN, Xia R, Du XL. Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 21: 1825-33. PMID 20211871 DOI: 10.1093/Annonc/Mdq042 |
0.405 |
|
2010 |
Du XL, Xia R, Hardy D. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. American Journal of Clinical Oncology. 33: 533-43. PMID 20023570 DOI: 10.1097/Coc.0B013E3181B9Cf1B |
0.415 |
|
2010 |
Hardy D, Cormier JN, Xing Y, Liu CC, Xia R, Du XL. Chemotherapy-associated toxicity in a large cohort of elderly patients with non-small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 90-8. PMID 19884853 DOI: 10.1097/Jto.0B013E3181C0A128 |
0.41 |
|
2010 |
Nurgalieva Z, Xia R, Liu CC, Burau K, Hardy D, Du XL. Risk of chemotherapy-induced peripheral neuropathy in large population-based cohorts of elderly patients with breast, ovarian, and lung cancer. American Journal of Therapeutics. 17: 148-58. PMID 19417586 DOI: 10.1097/Mjt.0B013E3181A3E50B |
0.767 |
|
2010 |
Cen P, Banki F, Cheng L, Kaiser LR, Khalil K, Du XL, Amato RJ. Dynamic changes in age, stage distribution, and survival of patients with esophageal adenocarcinoma over three decades in the United States. Journal of Clinical Oncology. 28: 4130-4130. DOI: 10.1200/Jco.2010.28.15_Suppl.4130 |
0.355 |
|
2010 |
White AL, Vernon SW, Franzini L, Du XL. Abstract B32: Racial/ethnic disparities and trends in screening for colorectal cancer among Medicare beneficiaries with cancer and those without cancer in SEER areas, 1992–2002 Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B32 |
0.632 |
|
2010 |
Gruschkus SK, Lairson DR, Dunn JK, Risser JMH, Du X. Abstract B129: Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly non‐Hodgkin's lymphoma patients Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-09-B129 |
0.759 |
|
2010 |
Sail K, Franzini L, Du X, Lairson D. PCN129 RACIAL DISPARITIES ASSOCIATED WITH TREATMENT AND SURVIVAL IN ELDERLY PATIENTS WITH EARLY STAGE OPERABLE BREAST CANCER Value in Health. 13: A48. DOI: 10.1016/S1098-3015(10)72218-X |
0.457 |
|
2010 |
Gruschkus S, Lairson D, Dunn J, Risser J, Du X. PCN76 COST-EFFECTIVENESS OF WHITE BLOOD CELL GROWTH FACTOR USE AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY Value in Health. 13: A38. DOI: 10.1016/S1098-3015(10)72165-3 |
0.728 |
|
2010 |
Gruschkus S, Lairson D, Dunn J, Risser J, Du X. PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS Value in Health. 13: A23. DOI: 10.1016/S1098-3015(10)72092-1 |
0.715 |
|
2009 |
Nurgalieva Z, Liu CC, Du XL. Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 1314-21. PMID 20009883 DOI: 10.1111/Igc.0B013E3181B7662D |
0.749 |
|
2009 |
Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K. Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer. Cancer. 115: 5296-308. PMID 19672997 DOI: 10.1002/Cncr.24621 |
0.396 |
|
2009 |
Badgwell BD, Chang GJ, Rodriguez-Bigas MA, Smith K, Lupo PJ, Frankowski RF, Delclos G, Du XL, Cormier J. Management and outcomes of anorectal infection in the cancer patient. Annals of Surgical Oncology. 16: 2752-8. PMID 19649556 DOI: 10.1245/S10434-009-0626-Y |
0.366 |
|
2009 |
Hardy D, Xia R, Liu CC, Cormier JN, Nurgalieva Z, Du XL. Racial disparities and survival for nonsmall-cell lung cancer in a large cohort of black and white elderly patients. Cancer. 115: 4807-18. PMID 19626650 DOI: 10.1002/Cncr.24521 |
0.748 |
|
2009 |
Bhargava A, Du XL. Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer. Cancer. 115: 2999-3008. PMID 19452539 DOI: 10.1002/Cncr.24363 |
0.442 |
|
2009 |
Taylor LG, Canfield SE, Du XL. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer. 115: 2388-99. PMID 19399748 DOI: 10.1002/Cncr.24283 |
0.365 |
|
2009 |
Hardy D, Liu CC, Xia R, Cormier JN, Chan W, White A, Burau K, Du XL. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer. Cancer. 115: 2199-211. PMID 19365824 DOI: 10.1002/Cncr.24248 |
0.648 |
|
2009 |
Holmes L, Chan W, Jiang Z, Ward D, Essien EJ, Du XL. Impact of androgen deprivation therapy on racial/ethnic disparities in the survival of older men treated for locoregional prostate cancer. Cancer Control : Journal of the Moffitt Cancer Center. 16: 176-85. PMID 19337204 DOI: 10.1177/107327480901600210 |
0.608 |
|
2009 |
Coker AL, Eggleston KS, Du XL, Ramondetta L. Ethnic disparities in cervical cancer survival among Medicare eligible women in a multiethnic population. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 19: 13-20. PMID 19258935 DOI: 10.1111/Igc.0B013E318197F343 |
0.425 |
|
2009 |
Du XL, Xia R, Liu CC, Cormier JN, Xing Y, Hardy D, Chan W, Burau K. Cardiac toxicity associated with anthracyxline-containing chemotherapy in older women with breast cancer (Cancer (2009) 115, (5296-5308)) Cancer. 115: 5849-5851. DOI: 10.1002/Cncr.24744 |
0.432 |
|
2008 |
Wang M, Burau KD, Fang S, Wang H, Du XL. Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma. Cancer. 113: 3231-41. PMID 18937267 DOI: 10.1182/Blood.V112.11.2360.2360 |
0.474 |
|
2008 |
White A, Liu CC, Xia R, Burau K, Cormier J, Chan W, Du XL. Racial disparities and treatment trends in a large cohort of elderly African Americans and Caucasians with colorectal cancer, 1991 to 2002. Cancer. 113: 3400-9. PMID 18932248 DOI: 10.1002/Cncr.23924 |
0.663 |
|
2008 |
Zhou Y, Wang H, Fang W, Romaguer JE, Zhang Y, Delasalle KB, Kwak L, Yi Q, Du XL, Wang M. Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer. 113: 791-8. PMID 18615506 DOI: 10.1002/Cncr.23608 |
0.315 |
|
2008 |
Du XL, Fang S, Meyer TE. Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer. American Journal of Clinical Oncology. 31: 125-32. PMID 18391595 DOI: 10.1097/Coc.0B013E3181587890 |
0.456 |
|
2008 |
Du XL, Fox EE, Lai D. Competing causes of death for women with breast cancer and change over time from 1975 to 2003. American Journal of Clinical Oncology. 31: 105-16. PMID 18391593 DOI: 10.1097/Coc.0B013E318142C865 |
0.445 |
|
2008 |
Liu L, Coker AL, Du XL, Cormier JN, Ford CE, Fang S. Long-term survival after radical prostatectomy compared to other treatments in older men with local/regional prostate cancer. Journal of Surgical Oncology. 97: 583-91. PMID 18381603 DOI: 10.1002/Jso.21028 |
0.349 |
|
2007 |
Rohatgi N, Du XL, Coker AL, Moye LA, Wang M, Fang S. Chemotherapy and survival for patients with multiple myeloma: findings from a large nationwide and population-based cohort. American Journal of Clinical Oncology. 30: 540-8. PMID 17921717 DOI: 10.1097/Coc.0B013E3180592A30 |
0.406 |
|
2007 |
Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 18: 660-9. PMID 17892451 DOI: 10.1111/J.1525-1438.2007.01081.X |
0.506 |
|
2007 |
Cabanillas ME, Lu H, Fang S, Du XL. Elderly patients with non-Hodgkin lymphoma who receive chemotherapy are at higher risk for osteoporosis and fractures. Leukemia & Lymphoma. 48: 1514-21. PMID 17701582 DOI: 10.1080/10428190701471973 |
0.393 |
|
2007 |
Du XL, Fang S, Vernon SW, El-Serag H, Shih YT, Davila J, Rasmus ML. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer. 110: 660-9. PMID 17582625 DOI: 10.1002/Cncr.22826 |
0.519 |
|
2007 |
Holmes L, Chan W, Jiang Z, Du XL. Effectiveness of androgen deprivation therapy in prolonging survival of older men treated for locoregional prostate cancer. Prostate Cancer and Prostatic Diseases. 10: 388-95. PMID 17486111 DOI: 10.1038/sj.pcan.4500973 |
0.611 |
|
2007 |
Du XL, Meyer TE, Franzini L. Meta-analysis of racial disparities in survival in association with socioeconomic status among men and women with colon cancer. Cancer. 109: 2161-70. PMID 17455219 DOI: 10.1002/Cncr.22664 |
0.464 |
|
2007 |
Berrios-Rivera JP, Fang S, Cabanillas ME, Cabanillas F, Lu H, Du XL. Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma. American Journal of Clinical Oncology. 30: 163-71. PMID 17414466 DOI: 10.1097/01.Coc.0000251356.63237.4F |
0.457 |
|
2007 |
Du XL, Gor BJ. Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002 Ethnicity and Disease. 17: 122-128. PMID 17274221 |
0.322 |
|
2006 |
Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL. Ethnic differences among patients with cutaneous melanoma. Archives of Internal Medicine. 166: 1907-14. PMID 17000949 DOI: 10.1001/Archinte.166.17.1907 |
0.389 |
|
2006 |
Sanderson M, Coker AL, Perez A, Du XL, Peltz G, Fadden MK. A multilevel analysis of socioeconomic status and prostate cancer risk. Annals of Epidemiology. 16: 901-7. PMID 16843007 DOI: 10.1016/J.Annepidem.2006.02.006 |
0.35 |
|
2006 |
Du XL, Fang S, Coker AL, Sanderson M, Aragaki C, Cormier JN, Xing Y, Gor BJ, Chan W. Racial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohort. Cancer. 106: 1276-85. PMID 16475208 DOI: 10.1002/Cncr.21732 |
0.376 |
|
2006 |
Du XL, Key CR, Dickie L, Darling R, Geraci JM, Zhang D. External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews. Medical Care. 44: 124-31. PMID 16434911 DOI: 10.1097/01.Mlr.0000196978.34283.A6 |
0.425 |
|
2006 |
Coker AL, Du XL, Fang S, Eggleston KS. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts. Gynecologic Oncology. 102: 278-84. PMID 16434087 DOI: 10.1016/J.Ygyno.2005.12.016 |
0.453 |
|
2006 |
Du XL, Key CR, Dickie L, Darling R, Delclos GL, Waller K, Zhang D. Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. Journal of Clinical Epidemiology. 59: 53-60. PMID 16360561 DOI: 10.1016/J.Jclinepi.2005.06.002 |
0.406 |
|
2005 |
Cormier JN, Xing Y, Ding M, Ross MI, Lee JE, Mansfield PF, Gershenwald JE, Du XL. Population based assessment of surgical treatment trends for melanoma patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7509. PMID 27946148 DOI: 10.1200/Jco.2005.23.16_Suppl.7509 |
0.317 |
|
2005 |
Du XL, Lairson DR, Begley CE, Fang S. Temporal and geographic variation in the use of hematopoietic growth factors in older women receiving breast cancer chemotherapy: findings from a large population-based cohort. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 8620-8. PMID 16314624 DOI: 10.1200/Jco.2005.02.6252 |
0.447 |
|
2005 |
Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer. Breast Cancer Research and Treatment. 93: 41-7. PMID 16184457 DOI: 10.1007/S10549-005-3702-4 |
0.478 |
|
2005 |
Du XL, Jones DV, Zhang D. Effectiveness of adjuvant chemotherapy for node-positive operable breast cancer in older women. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 60: 1137-44. PMID 16183952 DOI: 10.1093/Gerona/60.9.1137 |
0.41 |
|
2005 |
Cormier JN, Xing Y, Ding M, Lee JE, Mansfield PF, Gershenwald JE, Ross MI, Du XL. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6054-62. PMID 16135473 DOI: 10.1200/Jco.2005.21.360 |
0.311 |
|
2005 |
Du XL, Chan W, Giordano S, Geraci JM, Delclos GL, Burau K, Fang S. Variation in modes of chemotherapy administration for breast carcinoma and association with hospitalization for chemotherapy-related toxicity. Cancer. 104: 913-24. PMID 15991239 DOI: 10.1002/cncr.21271 |
0.307 |
|
2005 |
Du XL, Key C, Dickie L, Darling R, Geraci J, Zhang D. 300: External Validation of Medicare Claims for Breast Cancer Chemotherapy Compared to Medical Chart Reviews American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S75C |
0.383 |
|
2004 |
Du XL, Key CR, Osborne C. Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. The Breast Journal. 10: 433-9. PMID 15327498 DOI: 10.1111/J.1075-122X.2004.21357.X |
0.392 |
|
2003 |
Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS. Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Annals of Internal Medicine. 138: 90-7. PMID 12529090 DOI: 10.7326/0003-4819-138-2-200301210-00009 |
0.33 |
|
2002 |
Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 4636-42. PMID 12488407 DOI: 10.1200/Jco.2002.05.088 |
0.406 |
|
2001 |
Du X, Goodwin JS. Increase of chemotherapy use in older women with breast carcinoma from 1991 to 1996 Cancer. 92: 730-737. PMID 11550141 DOI: 10.1002/1097-0142(20010815)92:4<730::AID-CNCR1376>3.0.CO;2-P |
0.308 |
|
2001 |
Du X, Goodwin JS. Patterns of use of chemotherapy for breast cancer in older women: Findings from medicare claims data Journal of Clinical Oncology. 19: 1455-1461. PMID 11230491 DOI: 10.1200/Jco.2001.19.5.1455 |
0.473 |
|
2001 |
Du X, Freeman DH, Syblik DA. What drove changes in the use of breast conserving surgery since the early 1980s? The role of the clinical trial, celebrity action and an NIH consensus statement. Breast Cancer Research and Treatment. 62: 71-9. PMID 10989987 DOI: 10.1023/A:1006414122201 |
0.329 |
|
2000 |
Du X, Freeman JL, Warren JL, Nattinger AB, Zhang D, Goodwin JS. Accuracy and completeness of Medicare claims data for surgical treatment of breast cancer. Medical Care. 38: 719-27. PMID 10901355 DOI: 10.1097/00005650-200007000-00004 |
0.382 |
|
1999 |
Du X, Freeman JL, Freeman DH, Syblik DA, Goodwin JS. Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995 Journals of Gerontology - Series a Biological Sciences and Medical Sciences. 54. PMID 10536651 DOI: 10.1093/Gerona/54.9.M474 |
0.39 |
|
1999 |
Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: The advantages of the linked Medicare and SEER data Journal of Clinical Epidemiology. 52: 463-470. PMID 10360342 DOI: 10.1016/S0895-4356(99)00011-6 |
0.443 |
|
1999 |
Du X, Freeman JL, Goodwin JS. The declining use of axillary dissection in patients with early stage breast cancer Breast Cancer Research and Treatment. 53: 137-144. PMID 10326790 DOI: 10.1023/A:1006170811237 |
0.444 |
|
Show low-probability matches. |